2 results match your criteria: "Institutes of Radioisotopes-Radiodiagnostic Products and Biology[Affiliation]"
J Med Chem
July 2009
Institutes of Radioisotopes-Radiodiagnostic Products and Biology, NCSR Demokritos, 15310 Athens, Greece.
The aim of the present study is the evaluation of the (99m)Tc complexes of two bombesin-like peptides: Gly1'-Gly2'-Cys3'-Aca-BN[2-14] (BN-1.1) and Gly1'-Gly2'-Cys3'-Aca-BN[7-14] (BN-1.1p).
View Article and Find Full Text PDFInorg Chem
September 2004
Institutes of Radioisotopes & Radiodiagnostic Products and Biology, National Centre for Scientific Research Demokritos, 153 10 Athens, Greece.
The decapeptide Arg-Gly-Asp-Ser-Cys-Arg-Gly-Asp-Ser-Tyr, which contains two Arg-Gly-Asp (RGD) moieties in its sequence, has been successfully labeled with radioactive rhenium (Re-188) yielding a single, stable oxorhenium complex. This complex is being evaluated for possible application in oncology as a target-specific radiotherapeutic agent, because its radioactive technetium-99m analogue has already been applied for the scintigraphic detection of malignant melanoma in humans. For structural characterization purposes, the complex of the decapeptide was synthesized at the macroscopic level using nonradioactive rhenium (Re-185/Re-187).
View Article and Find Full Text PDF